Literature DB >> 29224712

Superior semicircular canal dehiscence: Diagnosis and management.

Christine Mau1, Naveed Kamal2, Saiaditya Badeti2, Renuka Reddy3, Yu-Lan Mary Ying3, Robert W Jyung3, James K Liu4.   

Abstract

The authors provide an update on the clinical manifestations, diagnosis and various approaches to the treatment of superior semicircular canal dehiscence (SSCD). SSCD is a rare condition where the bone overlying the superior semicircular canal thins or dehisces causing characteristic clinical findings. Since this was first reported in 1998 by Minor and colleagues, there has been much advancement made in terms of diagnosis and treatment. Signs and symptoms include a wide variation of both vestibular and auditory manifestations. Diagnosis made solely on clinical signs is difficult due to how varied the presentations can be and the overlap with other otologic pathologies. High-resolution CT temporal scans have been the standard in confirming superior semicircular canal dehiscence, however, MRI FIESTA scans have recently been used to image SSCD. Additionally, audiometry and vestibular evoked myogenic potential (VEMP) testing are useful screening tools. Currently, the middle fossa approach is the most common and standard surgical approach to repair SSCD. The transmastoid, endoscopic and transcanal or endaural approaches have also been recently utilized. Presently, there is no consensus as to the best approach, material or technique for repair of SSCD. As we learn more, newer and less invasive approaches and techniques are being used to treat SSCD. We present a comprehensive review of SSCD, including clinical symptoms and presentation, histopathology, diagnosis, treatment strategies and outcomes of intervention.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Keywords:  Neurosurgery; Otolaryngology; SSCD; Superior semicircular canal dehiscence; Surgical techniques

Mesh:

Year:  2017        PMID: 29224712     DOI: 10.1016/j.jocn.2017.11.019

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  8 in total

1.  Editorial: The Magic of Spells.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

2.  Prevalence of Superior Semicircular Canal Dehiscence on High-Resolution CT Imaging in Patients without Vestibular or Auditory Abnormalities.

Authors:  A W Berning; K Arani; B F Branstetter
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-28       Impact factor: 3.825

3.  Case Report: Fremitus Nystagmus in Superior Canal Dehiscence Syndrome.

Authors:  Miranda Morrison; Athanasia Korda; Franca Wagner; Marco Domenico Caversaccio; Georgios Mantokoudis
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

Review 4.  Beyond Tympanomastoidectomy: A Review of Less Common Postoperative Temporal Bone CT Findings.

Authors:  A Panda; M L Carlson; F E Diehn; J I Lane
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-12       Impact factor: 3.825

5.  Proposal for a Unitary Anatomo-Clinical and Radiological Classification of Third Mobile Window Abnormalities.

Authors:  Pierre Reynard; Samar Idriss; Aicha Ltaief-Boudrigua; Pierre Bertholon; Andreea Pirvan; Eric Truy; Hung Thai-Van; Eugen C Ionescu
Journal:  Front Neurol       Date:  2022-01-11       Impact factor: 4.003

6.  Asymptomatic multiple semicircular canal dehiscence: a rare entity.

Authors:  Walid Bijou; Zineb El Krimi; Bushra Abdulhakeem; Youssef Oukessou; Mohamed Mahtar
Journal:  Oxf Med Case Reports       Date:  2022-07-26

7.  Development of semicircular canal occlusion.

Authors:  Su Fei; Li Guangfei; Meng Jie; Gao Yiling; Cai Mingjing; Zhang Qingxiang; Meng Wei; He Shuangba
Journal:  Front Neurosci       Date:  2022-08-19       Impact factor: 5.152

8.  Can Wideband Tympanometry Be Used as a Screening Test for Superior Semicircular Canal Dehiscence?

Authors:  Emine Demir; Nazife Nur Afacan; Metin Celiker; Fatma Beyazal Celiker; Mehmet Fatih İnecikli; Suat Terzi; Engin Dursun
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-11-22       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.